Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.
van der Ploeg EK, Krabbendam L, Vroman H, van Nimwegen M, de Bruijn MJW, de Boer GM, Bergen IM, Kool M, Tramper-Standers GA, Braunstahl GJ, Huylebroeck D, Hendriks RW, Stadhouders R. van der Ploeg EK, et al. Among authors: de boer gm. Nat Commun. 2023 Aug 23;14(1):5137. doi: 10.1038/s41467-023-40820-x. Nat Commun. 2023. PMID: 37612281 Free PMC article.
Bronchoscopy: Oral or Nasal Insertion?
de Boer GM, Türk Y, Meuleman-van Waning VH, Braunstahl GJ. de Boer GM, et al. J Bronchology Interv Pulmonol. 2017 Apr;24(2):125-130. doi: 10.1097/LBR.0000000000000356. J Bronchology Interv Pulmonol. 2017. PMID: 28323725 Clinical Trial.
Increased surface expression of NOTCH on memory T cells in peripheral blood from patients with asthma.
Tindemans I, Vroman H, Lukkes M, van Nimwegen M, de Bruijn MJW, Li BWS, Kleinjan A, de Boer GM, Tramper-Stranders GA, Kool M, Braunstahl GJ, Hendriks RW. Tindemans I, et al. Among authors: de boer gm. J Allergy Clin Immunol. 2019 Feb;143(2):769-771.e3. doi: 10.1016/j.jaci.2018.09.012. Epub 2018 Oct 5. J Allergy Clin Immunol. 2019. PMID: 30296524 No abstract available.
Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.
van der Ploeg EK, Golebski K, van Nimwegen M, Fergusson JR, Heesters BA, Martinez-Gonzalez I, Kradolfer CMA, van Tol S, Scicluna BP, de Bruijn MJW, de Boer GM, Tramper-Stranders GA, Braunstahl GJ, van IJcken WFJ, Nagtegaal AP, van Drunen CM, Fokkens WJ, Huylebroeck D, Spits H, Hendriks RW, Stadhouders R, Bal SM. van der Ploeg EK, et al. Among authors: de boer gm. Sci Immunol. 2021 Jan 29;6(55):eabd3489. doi: 10.1126/sciimmunol.abd3489. Sci Immunol. 2021. PMID: 33514640
Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.
de Boer GM, Braunstahl GJ, van der Ploeg EK, van Zelst CM, van Bruggen A, Epping G, van Nimwegen M, Verhoeven G, Birnie E, Boxma-de Klerk BM, de Bruijn MJW, Stadhouders R, Hendriks RW, Tramper-Stranders GA. de Boer GM, et al. Clin Exp Allergy. 2021 Sep;51(9):1172-1184. doi: 10.1111/cea.13990. Epub 2021 Aug 6. Clin Exp Allergy. 2021. PMID: 34289183 Free PMC article. Clinical Trial.
15 results